U.S. Biotech Stock News

Kinder Morgan, Inc. ( NYSE:KMI ) just released its quarterly report and things are looking bullish. The company beat...

CareTrust REIT has delivered a strong share price run over the past three years, yet the current checks paint a mixed valuation picture that leaves investors weighing a solid return record against only a partial signal that the stock is still cheap on fundamentals. The stock has returned 137.7% over three years, which puts recent gains at the center of any discussion about whether new buyers are paying up for that performance. Future rent growth and cash flows from its healthcare-focused...

Freedom Holding (FRHC) drew fresh investor attention after signing Memoranda of Understanding with Antom, a payment services provider under Ant International, to build cross border payment solutions for Kazakhstani users shopping on Chinese e commerce platforms. See our latest analysis for Freedom Holding. At a share price of $151.02, Freedom Holding has pulled back slightly over the last week but still shows a 30 day share price return of 11.49% and a year to date share price return of...

SS&C Technologies Holdings (SSNC) has reported a clean set of Q2 2026 numbers, with revenue of US$1.7 billion and basic EPS of US$0.99, alongside trailing 12 month EPS of US$3.58. Over the past few quarters the company has seen revenue move from US$1.54 billion in Q2 2025 to US$1.70 billion in Q2 2026, while basic EPS has risen from US$0.74 to US$0.99. This puts the focus on how a 13.2% trailing net margin shapes the quality of these results for investors. See our full analysis for SS&C...

Alignment Healthcare stock has delivered a very strong 237.9% return over the past three years, yet its valuation checks still suggest the shares screen as cheap rather than stretched. That contrast is now running head on into fresh legal and regulatory questions that could affect how investors think about the quality and sustainability of the company’s earnings. A 237.9% three year gain positions Alignment Healthcare as a major winner over that period, so any hint that its growth story is...

With markets fixated on geopolitics, energy prices, and shifting inflation signals, many investors are looking for themes tied to long term structural change rather than short term headlines. Artificial intelligence in healthcare sits squarely in that camp, with potential to improve diagnostics, treatment decisions, and productivity across systems facing cost pressure. The Transformative AI Healthcare Stocks screener helps filter companies exposed to this trend, while you keep an eye on macro...

Ball (BALL) is drawing fresh attention after recent share price moves, with the stock closing at $63.84 compared with a widely discussed fair value marker of $70.79 that points to a possible valuation gap. See our latest analysis for Ball. Recent moves in Ball's share price, including the 1 day share price return of 2.59% and year to date share price return of 19.66%, come alongside a fair value narrative of $70.79 and a discounted cash flow estimate that points to a potential valuation gap...

With the Federal Reserve sending mixed signals on future rate cuts and hikes, inflation estimates edging higher, and oil prices reacting to conflict in Iran, many investors are taking a fresh look at large cap defensive dividend stocks. These companies, often in Consumer Staples, Utilities, and Healthcare, are commonly viewed as potential anchors when monetary policy and inflation expectations feel uncertain. This article focuses on how that backdrop connects to our US Large Cap Defensive...

Avnet stock has delivered a strong 145.2% return over the past 5 years, yet the company scores poorly on broader valuation checks, leaving investors weighing a solid track record against signals that the shares may not be a simple bargain at the current US$89.42 price. Over 5 years, Avnet has returned 145.2%, which puts recent gains into context as investors assess how much of the story is already reflected in the share price. Avnet's ability to convert its electronics distribution business...

Recent coverage of InvenTrust Properties (IVT) is centering on its pattern of annual dividend increases, a moderate payout ratio, and analyst expectations for earnings growth, all of which are drawing fresh attention from income-focused investors. See our latest analysis for InvenTrust Properties. At a share price of $36.45, InvenTrust Properties has posted a 12.12% 90 day share price return and a 30.74% year to date share price return. The 1 year total shareholder return of 36.62% and 3 year...

Tenet Healthcare (THC) has reported another strong quarter, with Q2 2026 revenue of US$6.1 billion, basic EPS of US$9.89 and net income excluding extraordinary items of US$826 million setting the tone. The company’s quarterly revenue increased from US$5.3 billion in Q2 2025 to US$6.1 billion in Q2 2026, while basic EPS rose from US$3.16 to US$9.89 over the same period. Trailing 12 month earnings growth of 51% has coincided with a net profit margin that improved to 9.9% from 7.2% a year...

DocuSign (DOCU) jumped 5.6% on July 24, 2026, as part of a broad rally in software stocks. This move gave investors fresh reason to reassess how the stock fits into current sector trends. See our latest analysis for DocuSign. For context, DocuSign’s 14.01% 1 month share price return and 9.13% 3 month share price return contrast with a year to date share price decline of 22.22% and a 1 year total shareholder return decline of 36.85%. This points to short term momentum but a still weak longer...

Old Republic International (ORI) just reported mixed quarterly results, with stronger Title Insurance profitability offset by weaker Specialty Insurance performance. Technology and data investments, the ECM acquisition, and ongoing buybacks shaped how investors reacted. See our latest analysis for Old Republic International. Old Republic International’s mixed quarter and active buyback have come alongside a 1 day share price return of 2.35% and a 30 day share price return of 4.94%. The 1 year...

Robotics and automation stocks sit at the crossroads of several forces investors are watching closely, from labor shortages and inflation pressures to shifting supply chains and energy uncertainty. As physical AI moves from pilot projects to wider deployment, some companies in the Robotics and Automation Stocks screener are aiming to turn that demand into revenue while keeping balance sheets under control. This article introduces the robotics theme in the context of central bank moves,...

In recent weeks, analysts have become more optimistic about Elastic’s earnings prospects, with upward revisions and a stronger consensus that the company may outperform prior profit expectations. This rising optimism around earnings quality and trajectory has become a key influence on how investors interpret Elastic’s role in the AI-powered data and search software space. We’ll now examine how this shift in analyst earnings expectations reshapes Elastic’s existing investment narrative built...

Global trade tensions are heating up again, with fresh US tariffs of 10% to 12.5% on imports from more than 60 countries and a swift response from China adding to supply chain uncertainty. For logistics and freight providers, this mix of higher costs, rerouted trade flows, and shifting customer demand can create both pressure and opportunity. This article discusses 3 stocks from our Global Logistics and Freight Providers screener that are directly exposed to the latest tariff moves and...

Volkswagen engineers have been charged with insider trading linked to the planned joint venture with Rivian Automotive, raising fresh legal and governance questions around NasdaqGS:RIVN and its largest shareholder. Rivian has filed a lawsuit against the US government seeking a refund of Trump-era tariffs, arguing the duties are unconstitutional and have inflated its input costs. These developments add new legal, regulatory, and reputational angles to the Rivian story beyond earlier debates...

Recently, analysts highlighted that Reinsurance Group of America is facing growth constraints versus smaller peers, with earnings per share lagging revenue gains and book value per share projected to fall over the next year amid softer capital generation. This commentary raises questions about the strength of RGA’s internal capital engine at a time when it remains a major life and health reinsurer globally. We’ll now examine how concerns over weakening capital generation and book value...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Fastenal Company ( NASDAQ:FAST ) stock is about to trade ex-dividend in two days. The ex-dividend date is one business...

Twenty One Capital (XXI) is back in focus after CEO Jack Mallers resigned on July 20, 2026, and board member Raphael Zagury stepped in as chief executive on the same date. See our latest analysis for Twenty One Capital. The CEO transition at Twenty One Capital comes after a sharp reset in investor expectations, with the share price down 42.05% over the past 90 days and the year to date share price return declining 51.40%. The 1 year total shareholder return has fallen 83.97%, pointing to...

Why Axsome Therapeutics Stock Is Back in Focus After the Latest FDA Milestone Axsome Therapeutics (AXSM) is drawing fresh attention after the U.S. Food and Drug Administration accepted its New Drug Application for AXS-12, an investigational treatment for cataplexy in narcolepsy, and set a PDUFA target action date of May 1, 2027. See our latest analysis for Axsome Therapeutics. For investors, the FDA’s acceptance of AXS-12 comes as Axsome Therapeutics’ share price has risen 29.6% over the past...

Columbia Sportswear stock has been weak over the past few years, yet the latest Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside compared with where the shares currently trade. At the same time, broader valuation checks suggest a mixed picture rather than a clear bargain or clear overvaluation. Over the past 5 years, Columbia Sportswear shares have declined about 32%, which puts recent returns out of step with the current DCF indication of undervaluation. For...

T-Mobile US (TMUS) has just posted Q2 2026 results with revenue of US$22.8 billion and basic EPS of US$2.99, alongside net income of US$3.2 billion that keeps profitability firmly in focus for investors. Over the past six quarters, the company has seen revenue range between US$20.1 billion and US$24.3 billion while quarterly EPS moved between US$1.89 and US$3.00, providing context for how this latest result fits into its recent history. With a trailing twelve month net margin of 11.5% and...